- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Integrating Palliative Care Professionals Into Practice: Will It Work?
Ted Okon, MBA, and Bruce Feinberg, DO, further discuss why end-of-life care for patients with cancer remains so challenging. Dr Feinberg notes that data now reveal an increase in intensive care unit use during the last month of a patient’s life, and larger numbers of patients being referred to hospice for 3 days or less.
In an effort to close gaps in end-of-life care and address patients’ advanced care planning concerns, accountable care organizations are now integrating palliative care physicians and nurses into oncology practices, explains Brian Kiss, MD. “They are integrating palliative care into the practice and into their processes from the beginning and that’s kind of an encouraging element,” says Dr Kiss.
However, Dr Feinberg highlights reasons why these changes may become problematic. Dr Feinberg explains that ACOs utilize a different reimbursement structure. Additionally, he is concerned that because palliative care physicians and nurses generate less income than medical oncologists, financial matters may impede the effects of these professionals to work as equal partners.
Balancing Cost and Quality in Oncology: A Value-Based Care Perspective
January 30th 2025Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based oncology care can achieve both cost efficiency and high-quality outcomes through integrated multidisciplinary teams, flexible payment models, and targeted treatment approaches.
Read More
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen
How FcRn Blockade Targets Myasthenia Gravis Autoantibodies
January 29th 2025In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent in treating adolescents who have the myasthenia gravis and how nipocalimab works via FcRn blockade to reduce the circulating autoantibodies that drive myasthenia gravis.
Read More
